Tech Company Financing Transactions
Spyryx Biosciences Funding Round
Private investors participated in a $5 million funding round for Spyryx Biosciences. The financing round was announced on 7/13/2017.
Transaction Overview
Company Name
Announced On
7/13/2017
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 13 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10 Capitola Dr. 801
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Website
Email Address
Overview
Spyryx Biosciences is developing next generation therapeutics for obstructive lung diseases with a particular focus on Cystic Fibrosis and COPD. We are dedicated to making a difference in the lives of patients and their families who bravely face these diseases every day.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Timothy Shannon
VP - Operations
Timm Crowder
Browse more venture capital transactions:
Prev: 7/13/2017: Aptrinsic venture capital transaction
Next: 7/13/2017: FairClaims venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs